Moleculin Biotech News

Moleculin Biotech | 8-K: Current report

Aug 19 16:13 ET

Moleculin Biotech | 8-K: Current report

Aug 16 16:54 ET

Moleculin Biotech | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Aug 15 11:22 ET

Moleculin Biotech | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Aug 15 06:17 ET

Moleculin Biotech | 8-K: Moleculin Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 14 08:09 ET

Moleculin Biotech | 8-K: Current report

Aug 6 09:13 ET

Moleculin Biotech | 8-K: Current report

Aug 5 09:07 ET

Moleculin Biotech | 8-K: Current report

Aug 1 08:36 ET

Moleculin Biotech | 8-K: Current report

Aug 1 08:36 ET

Moleculin Biotech | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jul 30 07:05 ET

Moleculin Biotech | S-1: General form for registration of securities under the Securities Act of 1933

Jul 22 17:37 ET

Moleculin Biotech | 8-K: Current report

Jul 10 08:34 ET

Moleculin Biotech | 8-K: Current report

Jun 18 17:03 ET

Moleculin Biotech | 8-K: Current report

Jun 14 08:04 ET

Moleculin Biotech | S-3: Registration statement for specified transactions by certain issuers

Jun 7 17:08 ET

Moleculin Biotech | 8-K: Current report

May 16 08:36 ET

Moleculin Biotech | 8-K: Current report

May 15 08:40 ET

Moleculin Biotech | 8-K: Current report

May 14 16:24 ET

Moleculin Biotech | 8-K/A: Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 13 10:54 ET

Moleculin Biotech | 8-K: Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 13 07:34 ET